These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37587612)

  • 1. Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy.
    Didona D; Schmidt MF; Maglie R; Solimani F
    J Dtsch Dermatol Ges; 2023 Oct; 21(10):1188-1209. PubMed ID: 37587612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
    Hammers CM; Stanley JR
    Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune bullous skin diseases, pemphigus and pemphigoid.
    Egami S; Yamagami J; Amagai M
    J Allergy Clin Immunol; 2020 Apr; 145(4):1031-1047. PubMed ID: 32272980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Skin Conditions: Autoimmune Blistering Disease.
    Helm M; Helm LA; Clebak KT; Foulke G
    FP Essent; 2023 Mar; 526():13-17. PubMed ID: 36913658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in pemphigus and pemphigoid diseases.
    Papara C; Zillikens D; Sadik CD; Baican A
    Autoimmun Rev; 2021 Jul; 20(7):102852. PubMed ID: 33971341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.
    Rashid H; Lamberts A; Diercks GFH; Pas HH; Meijer JM; Bolling MC; Horváth B
    Am J Clin Dermatol; 2019 Dec; 20(6):847-861. PubMed ID: 31313078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Clinical Trials in Pemphigus and Pemphigoid.
    Izumi K; Bieber K; Ludwig RJ
    Front Immunol; 2019; 10():978. PubMed ID: 31130959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
    Amber KT; Maglie R; Solimani F; Eming R; Hertl M
    Drugs; 2018 Oct; 78(15):1527-1548. PubMed ID: 30238396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell adhesion molecules and extracellular matrix components as target structures of autoimmunity].
    Moll R; Bahn H; Bayerl C; Moll I
    Verh Dtsch Ges Pathol; 1996; 80():67-79. PubMed ID: 9065056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review).
    Costan VV; Popa C; Hâncu MF; Porumb-Andrese E; Toader MP
    Exp Ther Med; 2021 Nov; 22(5):1335. PubMed ID: 34630689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular diagnosis of autoimmune dermatoses].
    Hoffmann K; Hertl M; Sitaru C
    Hautarzt; 2016 Jan; 67(1):33-9. PubMed ID: 26612472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways.
    Ellebrecht CT; Maseda D; Payne AS
    J Invest Dermatol; 2022 Mar; 142(3 Pt B):907-914. PubMed ID: 34756581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.
    Kartan S; Shi VY; Clark AK; Chan LS
    Am J Clin Dermatol; 2017 Feb; 18(1):105-126. PubMed ID: 27878477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus: Current and Future Therapeutic Strategies.
    Didona D; Maglie R; Eming R; Hertl M
    Front Immunol; 2019; 10():1418. PubMed ID: 31293582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.